top of page

Why are medications still predominantly manufactured in mass production?

Are patients not individuals with very different needs?

The future of disease treatment lies in personalised medication.

Yet, in one of the most critical aspects of human life, health, treatment still follows the principle of overdosing with mass-produced off-the-shelf drugs. Why is that? Is there truly no better new technology available?

Actually, there is, as presented in the following article.

With sincere thanks to Prof. Dennis Douroumis, Director of the Centre for Research Innovation (CRI) in the UK, Elena Arribas López, and the team for the comprehensive study on the manufacturing of personalised tablets with PrivMed® X AB®.


bottom of page